Lenskart vs Titan EyeCare: post-IPO scorecard shows margin gap widening in India's ₹30,000-crore eyewear race

Lenskart posts 24% YoY revenue growth to ₹2,146.6 crore with 19.8% EBITDA margin and 69.2% product margin on in-house manufacturing edge, while Titan EyeCare's EBIT falls to ₹12 crore from ₹24 crore despite footfall gains and 871-store network.

— FiledMon, 20 Jul, 2026, 15:36 IST·First seen Mon, 20 Jul, 2026, 15:35 IST·Source Financial Express · BrandWagon

What happened

Lenskart vs Titan EyeCare compete in India's eyewear market post-Lenskart IPO; Lenskart leads on margins and manufacturing scale, Titan EyeCare sees profit

Key facts

  • Rs 390 listing price
  • Rs 402 issue price
  • -2.23% 1-month Lenskart
  • +0.99% 1-month Titan
  • +10.85% 1-year Titan
  • $9.2 billion eyewear market
  • Rs 30,000 crore market est.
  • Titan <12% share
  • 9.3 million eye tests H1
  • 46% first-time users
  • 203 net new stores
  • 431 cities
  • 871 EyeCare stores
  • 69.2% Q2 product margin
  • 35-40% manufacturing cost advantage
  • 4 million frames H1
  • Rs 2,146.6 crore Q2 revenue
  • 24% YoY growth
  • Rs 425.8 crore EBITDA
  • 19.8% EBITDA margin
  • 19.5% H1 EBITDA margin vs 17.3%
  • Rs 215 crore Titan EyeCare income
  • Rs 199 crore prior
  • Rs 12 crore EBIT vs Rs 24 crore
  • 5.3-5.7% margin

Why this matters

The diverging margin trajectories—Lenskart's manufacturing-led efficiency gains versus Titan EyeCare's cost pressure despite 871 stores—flag eyewear supply-chain integration as a potential acquisition or partnership thesis worth tracking.

What to watch

  • Titan EyeCare quarterly EBIT trend (further decline vs stabilization)
  • Lenskart's next capex/manufacturing expansion announcements
  • Any Titan store-count reduction or franchise conversion news
  • Price movements on comparable frame/lens SKUs across both brands
  • New entrant or private-equity backed eyewear chain scaling in same price band
  • Lenskart post-IPO stock performance vs guidance (market validation of margin narrative)
  • Titan Eyecare likely announces cost-rationalization or store-format overhaul (smaller format, franchise-heavy) in next 1-2 quarters
  • Lenskart may deepen in-house manufacturing capacity (new plants) to lock in margin edge and deter price competition
  • Titan could bundle eyewear more tightly with Tata CLiQ/Titan watches ecosystem for cross-sell defense
  • Both players likely to expand direct-to-consumer digital/AI try-on tools to reduce customer acquisition cost
  • Watch for Titan management commentary on EyeCare segment in next Tata group earnings call — possible strategic review signal